BECKMAN COULTER

Brea, California, United States  All United States companies → — Founded 1935
Healthcare Conglomerate Medical Device / Hardware Point-of-Care Diagnostics
Hematology Laboratory Medicine
Lab & Diagnostics
Acquired by Danaher Corporation in 2011 — N/A (Subsidiary of Public Company)

Products

UNICEL DXH 800 COULTER CELLULAR ANALYSIS
BECKMAN COULTER
Lab & Diagnostics
The Beckman Coulter UniCel DxH 800 is an automated hematology analyzer for clinical laboratories, providing high-definition cellular analysis for complete blood counts, WBC differentials, NRBCs, and reticulocytes.

See all 1 product →

About BECKMAN COULTER

Beckman Coulter is a global leader in clinical diagnostics and life science research, dedicated to advancing healthcare through innovative biomedical testing solutions. The company develops, manufactures, and markets a comprehensive portfolio of instruments, reagents, and software designed to simplify, automate, and innovate complex laboratory processes. These diagnostic solutions are critical for routine and specialized clinical testing, supporting hospitals, reference laboratories, and physician offices worldwide in areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking.

In a significant move towards modernizing laboratory operations and enhancing clinical decision-making, Beckman Coulter is increasingly integrating artificial intelligence (AI) into its offerings. This includes the acquisition of StoCastic, LLC, an AI company providing evidence-based decision support for emergency departments, with its TriageGo tool designed to optimize patient triage and reduce critical decision times. Furthermore, Beckman Coulter has partnered with Innovaccer to leverage its enterprise data and AI platform, Gravity, to unify diagnostic, operational, and utilization data across laboratory systems. This initiative aims to provide AI-ready insights, enable intelligent automation, and transform raw data into actionable operational and clinical intelligence, ultimately improving efficiency, optimizing test utilization, and supporting better patient care decisions.

Focus Areas

Biomedical testing clinical diagnostics life sciences laboratory automation in vitro diagnostic systems reproductive health AI-enabled clinical decision support flow cytometry genomics particle analysis liquid handling hematology immunoassay clinical chemistry

Business Intelligence

Key InvestorsN/A (Subsidiary of Danaher Corporation)
PartnershipsInnovaccer (AI and Data Platform for Clinical Laboratory Operations Modernization, March 2026), Automata (AI-Ready Laboratory Automation, January 2026), Scopio Labs (Digital Bone Marrow Imaging and Analysis, September 2024; Hematology Digital Cell Morphology Platform, July 2022), Biogen and Fujirebio (Blood-Based Biomarkers for Tau Pathology in Alzheimer's Disease, July 2024), MeMed (Host Immune Response Diagnostics, May 2024), Mass General and BARDA (Identify Severe Pediatric Infections, July 2022), Smart4Diagnostics (Close data gap between blood collection and lab analysis, May 2022)
AcquisitionsStoCastic, LLC (AI company for emergency department decision support, October 2022), ValitaCell Ltd. (biotechnology company for biopharmaceutical development, 2022), Cytobank (2019), LabCyte (2019), Xitogen Technologies (2014), Iris Diagnostics and IRIS International, Inc. (Urinalysis Diagnostic, 2012), Advalytix AG (2009), Cogenics (2009), Lab-based Diagnostics business of Olympus Corporation Japan (2009), Lumigen (2006), Coulter Corporation (1997/1998)
TechnologyAI-enabled Clinical Decision Support (CDS) portfolio (e.g., TriageGo), Innovaccer Gravity platform (enterprise data and AI platform for lab operations), integration with Automata's AI-ready automation platform, digital hematology with AI and machine learning capabilities, cloud-native solutions for data management.
FDA ClearancesMultiple, including: DxC 500i Clinical Analyzer (510(k) clearance, March 2025), Alzheimer's Disease Blood Test (Breakthrough Device Designation, January 2025), Heart Failure Assay on DxI 9000 Immunoassay Analyzer (May 2024), DxC 500 AU Chemistry Analyzer (July 2023), AQUIOS STEM System for stem cell analysis (510(k) clearance, December 2023), DxA 5000 total laboratory automation solution (510(k) clearance, October 2019), PK7400 Automated Microplate System (510(k) clearance, July 2020), Access SARS-CoV-2 IgG assay (EUA, June 2020), Access Interleukin-6 (IL-6) assay (EUA), Access SARS-CoV-2 IgG II antibody assay (EUA) [cite: 31 in previous search]. TriageGo, an AI-enabled Clinical Decision Support tool, is actively used in US health systems, implying regulatory compliance. A comprehensive total for all products is not publicly available. cleared products (estimated)

What Physicians Need to Know

Clinical Diagnostics & Biomedical Testing
Beckman Coulter offers a comprehensive menu of assays for clinical chemistry, immunoassay, and hematology, supporting critical decisions in cardiology, infectious diseases, and more. Their systems range from low to ultra-high volume, emphasizing speed, accuracy, and reliability. Key innovations include the DxI 9000 Immunoassay Analyzer with no daily maintenance and the Access MeMed BV assay for rapid bacterial vs. viral differentiation. Hematology analyzers provide 5-part differentials with proprietary dynamic-gating methodology for enhanced accuracy and reduced manual reviews.
Life Sciences & Laboratory Automation
In life sciences, Beckman Coulter provides advanced solutions for flow cytometry, genomics, particle analysis, and liquid handling. Their CytoFLEX platform, including the modular CytoFLEX mosaic Spectral Detection Module, offers high sensitivity and up to 88 detection channels, simplifying complex multicolor experiments. The DxFLEX Clinical Flow Cytometer utilizes APD detector technology for superior sensitivity. For genomics, the Biomek Echo One System and Biomek i7 Automated Liquid Handlers accelerate high-throughput genomic sample preparation and single-cell assay workflows. Their laboratory automation systems, such as the DxA 5000 series, streamline pre- and post-analytical processes, reducing manual steps, improving efficiency, and optimizing lab space.
AI-enabled Clinical Decision Support
Beckman Coulter is advancing AI in healthcare through solutions like TriageGo, acquired from StoCastic, which provides evidence-based decision support for hospital emergency departments. TriageGo integrates with Electronic Health Record (EHR) systems and ED workflows, demonstrating reductions in critical decision-making times. They also leverage AI for early sepsis assessment using the Monocyte Distribution Width (MDW) parameter.
Reproductive Health
The company offers a comprehensive menu for monitoring reproductive health, including fertility assessment, pregnancy monitoring, and reproductive aging. Notable assays include Access AMH for predicting ovarian response in IVF treatments and the Access Total u03b2hCG (5th IS) assay, which is standardized and aids in Down syndrome assessment in Europe.
Physician Tip

For physicians, Beckman Coulter stands out by delivering smarter, faster diagnostic solutions that directly impact patient care. Their rapid and accurate diagnostic tests, such as cardiac panels and the bacterial/viral differentiation assay, enable quicker, more informed treatment decisions, especially in critical situations. AI-enabled clinical decision support tools like TriageGo can significantly reduce wait times and improve patient flow in emergency departments, leading to better outcomes. The comprehensive insights provided by advanced analytics, including spectral flow cytometry and detailed hematology differentials, offer a more complete understanding of complex patient conditions. Furthermore, their commitment to laboratory automation ensures consistent, reliable results and frees up lab personnel, indirectly supporting physicians with timely and dependable diagnostic information.

Beckman Coulter's solutions are designed for seamless integration within laboratory and healthcare ecosystems. Their Life Sciences division integrates Biomek liquid handlers with over 300 third-party devices from more than 60 manufacturers, and partners with companies like 10x Genomics and IDT to automate complex genomic workflows. On the diagnostics side, AI-powered tools like TriageGo are built to integrate with Electronic Health Record (EHR) systems. Cloud-based middleware solutions such as DxONE Workflow Manager and REMISOL Advance provide centralized management of laboratory instrumentation and data, enhancing accessibility, security, and operational efficiency across healthcare networks.

Products by BECKMAN COULTER

1 product in the directory

UNICEL DXH 800 COULTER CELLULAR ANALYSIS
BECKMAN COULTER
Lab & Diagnostics
The Beckman Coulter UniCel DxH 800 is an automated hematology analyzer for clinical laboratories, providing high-definition cellular analysis for complete blood counts, WBC differentials, NRBCs, and reticulocytes.

What the Web Says

Beckman Coulter generally receives mixed reviews as both an employer and a product provider. While some employees appreciate the pay and benefits, others express concerns about job security, management, and work-life balance. Product reviews are also varied, with some instruments praised for their capabilities and ease of use, while others are criticized for being labor-intensive, having software issues, or lacking adequate customer support.

Overall: Mixed

Strengths

  • Good pay and benefits for employees
  • Opportunities to learn new things and meet personal goals
  • Some products are considered reliable and have good QC performance
  • Certain instruments are noted for ease of use and intuitive software for beginners
  • Ability to customize and versatility in some liquid handling platforms
  • Collaborative environment and opportunities for professional development (employer)

Limitations

  • Constant reorganizations and frequent layoffs lead to job insecurity
  • Poor management, lack of clear direction, and toxic work environments reported by employees
  • Work-life balance concerns
  • Some products are labor-intensive, require extensive maintenance, and have software issues
  • Lack of innovation and slow to no advancement in some product lines
  • Poor customer service and technical support for some products, especially in certain regions

Based on reviews from: Indeed.com, Reddit, Comparably, Biocompare Product Review, SelectScience, The Mislabeled Specimen Analyzer Reviews, ZipRecruiter, IndexBox

Last updated: 2026-07-21

Videos

News, demos, and interviews about BECKMAN COULTER.

Loading videos...

Videos load interactively. If none appear, search YouTube for BECKMAN COULTER →

View all on YouTube

Press & Coverage

Beckman Coulter
Beckman Coulter Diagnostics Expands Alzheimer's Portfolio with CE-Marked p-Tau217 Blood Test and New High-Specificity Research Assay
Beckman Coulter Diagnostics has expanded its Alzheimer's portfolio with a CE-Marked p-Tau217 blood test and a new high-specificity research assay, designed to support the clinical evaluation of amyloid pathology in patients with cognitive decline.
2026-07
Beckman Coulter
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs. Viral Infection Results in Approximately 20 Minutes
Beckman Coulter Diagnostics has received CE Mark for a new assay that differentiates between bacterial and viral infections in about 20 minutes, with modeling suggesting it could cut up to u20ac80M in avoidable costs across European health systems.
2026-04
Beckman Coulter Life Sciences
Beckman Coulter Life Sciences and Automata Announce Strategic Partnership for AI-Ready Automation Platform
Beckman Coulter Life Sciences and Automata have partnered to integrate Beckman Coulter's liquid handling, genomic, and cell analysis technologies with Automata's AI-ready automation platform, aiming for faster, more consistent, and scalable experimentation in research.
2026-01
Beckman Coulter
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
Beckman Coulter Diagnostics received 510(k) clearance from the FDA for its new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay system designed to meet the demands of modern healthcare with high throughput.
2025-03
Beckman Coulter
Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer's Disease Blood Test
Beckman Coulter Diagnostics has been granted FDA Breakthrough Device Designation for its Access pu2011Tau217/u03b2-Amyloid 1-42 plasma ratio blood test, intended to help identify patients with amyloid pathology associated with Alzheimer's disease.
2025-01
Beckman Coulter Life Sciences
$2.5 Million Grant Awarded to Indiana University School of Medicine, Beckman Coulter Life Sciences to Expand Leukemia and Lymphoma Testing in Africa
Beckman Coulter Life Sciences and Indiana University School of Medicine received a $2.5 million grant from the National Cancer Institute to expand access to leukemia and lymphoma testing in Western Kenya over five years.
2025-01
Beckman Coulter
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Beckman Coulter and Scopio Labs have expanded their partnership to include the world's first digital bone marrow imaging and analysis, further integrating digital cell morphology into hematology workflows.
2024-09
Beckman Coulter
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer's Disease
Biogen, Beckman Coulter, and Fujirebio are collaborating to identify and develop accessible, minimally invasive blood-based biomarkers specifically for tau pathology in Alzheimer's disease.
2024-07

Frequently Asked Questions

Beckman Coulter provides a comprehensive portfolio of in vitro diagnostic solutions, including scalable clinical chemistry and immunoassay analyzers like the DxC and DxI series, which optimize workflows and support critical clinical decisions across various lab sizes. These systems, along with their hematology and reproductive health assays, aim to improve reliability, simplify operations, and offer standardized performance for enhanced laboratory efficiency and patient care.
Beckman Coulter Life Sciences empowers scientific discovery with automation and innovation solutions across centrifugation, flow cytometry, genomics, particle analysis, and liquid handling workflows. Key innovations include partnerships like the one with Rarity Bioscience for molecular research in flow cytometry, and collaborations with 10x Genomics to automate single-cell assay workflows, aiming to provide greater speed, accuracy, and advanced analytics for research.
Beckman Coulter is actively integrating AI-enabled clinical decision support (CDS) into its diagnostic platforms, notably through the acquisition of StoCastic and its TriageGo tool for emergency departments. This strategy combines biomarkers with evidence-based CDS to generate advanced insights, enabling clinicians to make informed decisions sooner and optimize laboratory operations with AI-based analytics.
Beckman Coulter is committed to achieving and maintaining compliance with global regulatory standards, including the In Vitro Diagnostic Regulation (IVDR) in the EU, and offers consultative support for operational qualification and instrument certification. The company also prioritizes data security and privacy, with a global product security team to assess vulnerabilities through a coordinated vulnerability disclosure process and a Global Privacy Notice outlining their data handling practices.
Beckman Coulter offers comprehensive support, training, and service programs to ensure optimal instrument performance and uptime. This includes online and onsite certified training through MyBeckman Learning, various service plans (e.g., Protective, Preventative Plus, Full Care), and technical support accessible via phone or online resources, including remote service tools like PRO Service for quicker issue resolution.
As a Danaher company, Beckman Coulter has a long-standing legacy of over 90 years of innovation, guided by the mission to 'Relentlessly Reimagine Healthcare, One Diagnosis at a Time.' They demonstrate stability and a commitment to future innovation through continuous improvement via the Danaher Business System and strategic partnerships, such as those with Innovaccer for laboratory modernization and Rarity Bioscience for advanced research, ensuring ongoing advancements in diagnostic solutions.

Related Companies

Google DeepMind is a leading artificial intelligence (AI) research laboratory, a subsidiary of Alphabet Inc., dedicated to developing advanced AI systems to benefit humanity. The company focuses on creating general-purpose AI that can learn and solve complex problems, drawing inspiration from neuroscience and machine learning. Their work spans various fields, including healthcare, scientific discovery, and […]

Tempus AI is a leading health technology company that leverages artificial intelligence (AI) and machine learning to advance precision medicine. Founded in 2015 by Eric Lefkofsky, the company was inspired by the need for more data-driven approaches in oncology care. Tempus has since built one of the world’s largest libraries of multimodal clinical and molecular […]

LabLynx is a privately held American laboratory informatics company that specializes in developing, supporting, and marketing Laboratory Information Management System (LIMS) solutions. The company has a long history in the industry, having introduced one of the first browser-based LIMS products in 1997. LabLynx’s primary offerings include ELab LIMS, a configurable cloud-based LIMS that serves various […]

August AI is a healthcare artificial intelligence company that has developed an AI-powered digital health companion. This platform is designed to provide accessible medical care and health guidance, acting as a ‘health companion’ rather than a replacement for clinical visits. It assists users in understanding symptoms, interpreting medical reports, and managing ongoing treatment. The company’s […]

Allergios® is a healthcare AI company focused on revolutionizing allergy diagnostics. The company has developed a method and system, based on research from the University of Bremen and Medical University of Vienna, that directly diagnoses allergies by visualizing the allergic response. Their solution involves an in-vitro allergy diagnostic that analyzes how patient blood serum induces […]

PNOĒ is a healthcare AI company that has developed a portable, clinical-grade metabolic analysis system. This system utilizes breath analysis (also known as metabolic testing or VO2max testing) to provide a comprehensive physiological assessment. The PNOĒ device measures oxygen consumption (VO2) and carbon dioxide production (VCO2) to evaluate 23 biomarkers related to metabolic rate, heart, […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.